Merck Serono S.A. - Geneva
Merck Serono is the division for innovative prescription pharmaceuticals of Merck, a global pharmaceutical and chemical group. Headquartered in Geneva, Switzerland, Merck Serono discovers, develops, manufactures and markets innovative small molecules and biopharmaceuticals to help patients with unmet medical needs. Its North American business operates in the United States and Canada as EMD Serono.
| Facts and Figures | |
| Managing Director | Elmar Schnee, Member of the Executive Board and General
Partner of Merck KGaA, and the President of Merck Serono |
| Number of employees | Over 17'000 worldwide |
| Total Revenues | Eur 4.5 billion in 2007 |
| Major products | Merck Serono has leading brands serving patients with cancer (Erbitux®), multiple sclerosis (Rebif®), infertility (Gonal-f®), endocrine and cardiometabolic disorders (Glucophage®, Concor®, Saizen®, Serostim®), as well as psoriasis (Raptiva®) |
